Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection

Summary

The aim of the study is to investigate whether the early introduction of maintenance bronchodilator therapy during an acute symptomatic episode of the disease shows benefits on the recovery of symptoms. It also represents an opportunity to identify COPD patients earlier in their disease state and start maintenance therapy, if appropriate.

Timeline

Start

2011-11

Primary completion

2012-12

Completion

2012-12

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Placebo vs Tiotropium 18 mcg; p = 0.3025; NCT01483625 ↗

Drugs

Indications